Piper Jaffray Companies started coverage on shares of Phreesia (NYSE:PHR) in a research note published on Monday morning, BenzingaRatingsTable reports. The brokerage issued an overweight rating and a $33.00 price objective on the stock.

Several other equities research analysts have also commented on PHR. Chardan Capital assumed coverage on shares of Phreesia in a research note on Tuesday, July 23rd. They set a buy rating and a $33.00 price target on the stock. William Blair assumed coverage on shares of Phreesia in a research note on Monday. They set an outperform rating on the stock. Five investment analysts have rated the stock with a buy rating, Phreesia currently has a consensus rating of Buy and an average target price of $30.50.

Phreesia stock opened at $25.25 on Monday. Phreesia has a 12-month low of $23.00 and a 12-month high of $29.38.

In related news, Director Scott Perricelli sold 743,388 shares of Phreesia stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total transaction of $13,380,984.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder Ii L.P. Chv sold 335,767 shares of Phreesia stock in a transaction on Monday, July 22nd. The stock was sold at an average price of $18.00, for a total transaction of $6,043,806.00. The disclosure for this sale can be found here.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

See Also: How Does the Quiet Period Work?

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.